Oxaliplatin other active pharmaceutical ingredients,,Active Pharmaceutical Ingredients,Other Active Pharmaceutical Ingredients
Is Manufacturer
No
Product Description
Assay: 98.0%-102.0%
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Oxaliplatin is a third-generation platinum-based chemotherapeutic agent. Its synthesis involves complex coordination chemistry to form the <strong>C6H10N2O4Pt</strong> structure (CAS: 61825-94-3). This active pharmaceutical ingredient serves as the core component for treating colorectal cancer.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Primary API for injectable formulations targeting metastatic colorectal carcinoma.</li>
<li><strong>Combination Therapy:</strong> Used in conjunction with fluoropyrimidines like leucovorin and 5-fluorouracil.</li>
<li><strong>Adjuvant Treatment:</strong> Administered post-surgery to reduce recurrence risk in Stage III colon cancer patients.</li>
</ul>
<h3>Precautions</h3>
<p>Requires strict cold-chain storage at -20°C to prevent degradation. Clinical use mandates avoidance of cold exposure due to neurotoxicity risks. Personnel must utilize PPE during compounding to mitigate occupational exposure hazards.</p>